Navigation Links
GeneNews' Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
Date:8/29/2007

- Text provides cardiologists with an overview of cardiovascular genetics

and genomics -

TORONTO, Aug. 29 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing patient-friendly blood-based biomarker tests for the detection and staging of virtually any disease or medical condition, today announced that its co-founder and Chief Scientist Dr. C.C. Liew, has co-edited a newly published genomics reference book entitled Cardiovascular Genetics and Genomics for the Cardiologist. The text provides cardiologists with an overview of cardiovascular genetics and genomics, which have been changing the fundamental understanding of cardiovascular disease and the practice of cardiovascular medicine.

"We are very proud of our Chief Scientist and the inventor of our core technologies, Dr. C.C. Liew. This is not only a significant achievement for Dr. Liew, but also an important and notable contribution to both the field of disease-specific genomics and the field of cardiovascular medicine," said K. Wayne Marshall, MD, PhD, President and Chief Executive Officer of GeneNews. "Dr. Liew is truly a pioneer in disease-specific genomics and has earned a global reputation for his outstanding scientific contributions in this cutting-edge area of healthscience."

Dr. Liew currently holds the positions of Visiting Professor of Medicine and Founding Director of the Cardiovascular Genome Unit at Brigham and Women's Hospital, Harvard Medical School, and Professor Emeritus at the University of Toronto. Genetics and Genomics for the Cardiologist is currently available from the publisher, Blackwell Publishing Inc. (http://www.blackwellcardiology.com).

About GeneNews

--------------

GeneNews is focused on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle(TM) in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews' first product in development, ColonSentry(TM), is a convenient and patient-friendly blood-based biomarker test that can detect colon cancer. For more information on GeneNews, visit http://www.genenews.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE GeneNews Limited
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. State technology chief endorses IT audit recommendations
2. Fusion 2007: CA chief says IT complexity raises risk
3. Web-Based Learning Developed under new Chief Education Officer
4. UW computer scientists fighting computer virus "Cold War"
5. UW scientist, former WiCell director found stem cell company
6. Scientists find way to make human collagen in lab
7. Wisconsin scientists to be recognized for innovative biofuel technology
8. UW biophysical scientist honored as society fellow
9. UW scientist wins Pew grant to study little-known immune cells
10. UW-Madison scientists to mimic nature for newest cancer drugs
11. The Scientist magazine names Madison "hotspot" for biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... Clinical Supplies ... has acquired the assets of Theorem Clinical Research - Clinical Supplies ("TCS"). ... trial drug packaging, labeling, storage, reconciliation, and distribution for pharmaceutical trials across ...
(Date:12/6/2016)... 6, 2016  The Texas Medical Center ... (HISA) today announced the establishment of a new ... Australia and the Texas Medical ... HISA and the Texas Medical Center, with ... create a global health innovation ecosystem where emerging technologies ...
(Date:12/5/2016)... , Dec 5, 2016 Research and ... "Biomarkers - Technologies, Markets and Companies" to their offering. ... , , ... their discovery using various -omics technologies such as proteomics and metabolomics. ... new tests are also based on biomarker. Currently the ...
(Date:12/5/2016)... 5, 2016 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or ... Data and Safety Monitoring Board (DSMB) for the ... disease (CVD) patients has completed a second planned ... continue as planned without any modifications. The DSMB ... safety or efficacy concerns were identified. The DSMB ...
Breaking Biology Technology:
(Date:12/6/2016)... , Dec. 6, 2016 Valencell , the ... it has seen a third consecutive year of triple ... technology in 2016 with a 360 percent increase in ... This increase was driven by sales of its wrist ... interest in its technology for hearables for fitness and ...
(Date:12/5/2016)... , Dec. 5, 2016  The Office of ... published "Can CT Scans Enhance or Replace Medico ... potential of supporting or replacing forensic autopsies with ... scan. In response to recommendations made ... exploring using CT scans as a potential component ...
(Date:12/2/2016)... Texas , Dec. 1, 2016   ... today announced BioLock , an electrocardiogram (ECG) ... health monitoring, a key IoT asset. The smart ... into a vehicle,s steering wheel and mobile devices ... simple touch. As vehicle technology advances, ...
Breaking Biology News(10 mins):